Given Imaging GIVENIMAGING User Manual Package Insert

Download:
Mirror Download [FCC.gov]
Document ID	135690
Application ID	pWKvLsQKPWU+Cxc10xQrOw==
Document Description	Package Insert
Short Term Confidential	No
Permanent Confidential	No
Supercede	No
Document Type	User Manual
Display Format	Microsoft Word - pdf
Filesize	8.77kB (109569 bits)
Date Submitted	2001-02-07 00:00:00
Date Available	2001-03-30 00:00:00
Creation Date	2001-02-07 22:37:41
Producing Software	Acrobat Distiller 4.0 for Windows
Document Lastmod	2001-02-07 22:37:43
Document Title	Package Insert

M2A™ Capsule (CAP2A)
Package Insert
ID#=O8PGIVENIMAGING
This device complies with Part 15 of the FCC rules. Operation is subject to the following two conditions: (1) this
device may not cause harmful interference, and (2) this device must accept any interference received, including
interference that may cause undesired operation.
! Caution: US Federal Law restricts this device to sale by or on the order of a physician.
Read this package insert in its entirety before using the M2A™ Capsule
Note: Changes or modifications not expressly approved by Given could void authority to
operate the Given® Imaging Diagnostic System.
Introduction
The M2A™ Capsule is an ingestable imaging capsule, which acquires video images while
traveling along the patient’s gastrointestinal tract, propelled by natural peristalsis until it is
excreted.
The M2A™ Capsule contains a miniscule color video camera with a flash, batteries, a
transmitter and an antenna to transmit the acquired images. All of these are encapsulated in a
26mm long and 11mm wide ingestable capsule made of biocompatible plastic.
Indications
The Given® Diagnostic Imaging System is intended for the detection of pathologies as an
adjunctive tool in the diagnosis of small bowel gastrointestinal disorders and diseases.
The Given® Diagnostic Imaging System may be used in hospitals, outpatient clinics and
physician offices. After the M2A™ Capsule is ingested the patient is not restricted to a
medical environment.
Contraindications
The M2A™ Capsule is contraindicated for use under the following conditions:
• In patients suspected to suffer from intestinal obstruction based on the clinical picture
or pre-procedure testing and profile.
• In patients with cardiac pacemakers or other implanted electromedical devices.
• During pregnancy
• With patients who have known or suspected gastrointestinal obstruction or strictures.
Prior abdominal surgery is a relative contraindication to the use of the M2A™
Capsule.
\\\DC - 69664/2 - #1258984 v1
Directions for Use
•
•
•
•
•
•
•
•
•
The physician should give the patient “Patient Instructions for Undergoing Capsule
Endoscopy”, printable from the RAPID™ Application and he/she should verify that
the patient understands the instructions.
The physician should instruct the patient to fast for 8 hours before the test and for
males to shave their abdomen 6 inches above and below the navel on the day of the
test.
When the patient comes to the clinic on the day of the test, the physician should
proceed according to instructions in the User Manual.
The physician should have the Sensor Array applied to the patient’s abdomen and
connected to the recorder in the Recorder Belt worn around his/her waist.
The physician should take the M2A™ Capsule out of its blister and test it according to
instructions in the User Manual.
If the tests are passed, the physician should instruct the patient to ingest the M2A™
Capsule with a sip of water.
If for any reason, after activating the M2A™ Capsule by removing it from its blister,
the patient is not taking the M2A™ Capsule, it should be deactivated by replacing it,
in its holder, to the blister. The capsule should stop blinking. If it does not stop on the
first attempt, turn the capsule in its holder and replace in blister until blinking stops.
Under normal conditions, the time elapsed between activating the capsule and
ingesting it should not exceed 1 minutes.
Before the patient leaves the clinic, the physician should verify that the patient has a
copy of “Patient Instructions for Undergoing Capsule Endoscopy” printable from the
RAPID™ Application and he/she should verify that the patient understands the
instructions.
Warnings
•
•
•
•
•
•
•
•
The M2A™ Capsule should be used only after consulting a physician.
A thorough understanding of the technical principles, clinical applications and risks
associated with the M2A™ Capsule is necessary before using this product.
The patient should thoroughly understand how he/she is required to behave during
Capsule Endoscopy.
In patients with strictures of the GI tract, the M2A™ Capsule can potenially cause
intestinal obstruction resulting in the need for hospitalization and surgery. The use of
the M2A™ Capsule in patients with strictures of the GI tract is contraindicated.
If there is reasonable doubt concerning the integrity of the M2A™ Capsule, it should
not be used until consulting with an authorized Given® representative and should be
deactivated by returning it in its holder into its blister.
The M2A™ Capsule should not be used after its expiration date.
The M2A™ Capsule is not to be ingested before it has been ascertained by a physician
that there is no other M2A™ Capsule or other swallowable diagnostic device within
the patient.
The patient should be instructed to avoid biting the M2A™ Capsule prior to
swallowing.
\\\DC - 69664/2 - #1258984 v1
•
•
•
•
•
•
•
After ingesting the M2A™ Capsule and until it is excreted, the patient should not be
near any source of powerful electromagnetic fields such as one created near an MRI
device.
If after ingesting the M2A™ Capsule the patient has any abdominal pain, nausea or
vomiting, he/she should contact the physician immediately.
This M2A™ Capsule must be stored, in a safe place out of the reach of children
and/or infants.
If contrary to instructions a patient ingested two capsules, he/she should be instructed
to contact the physician immediately.
If a child has accidentally swallowed an unused or spent M2A™ Capsule, he should
be brought immediately to a hospital.
The M2A™ Capsule should be ingested only in the presence of authorized personnel.
The patient should be instructed not to let his/her relatives, neighbors or acquaintances
use the M2A™ Capsule.
This device has not been tested in pediatric population (children 18 and below) and
safety in young children is unknown.
How will the M2A™ Capsule affect the daily routine of the patient?
The patient will have to prepare for Capsule Endoscopy in the following manner:
• The patient will have to abstain from eating or drinking for 8 hours before undergoing
this test.
• The patient may take medication up till two hours before and resume once again two
hours after M2A ingestion, with a sip of water.
• The patient will have to shave his abdomen 6 inches above and below the navel on the
day of the test (for males).
• At the physician’s office, a Sensor Array will be put on the patient’s abdomen and will
be connected to a recorder worn on a belt around his/her waist for the duration of the
test. The patient will then be instructed to ingest the M2A™ Capsule.
• After ingesting the capsule, the patient will have to abstain from eating or drinking for
another 2 hours. After 2 hours the patient may drink water. Four hours after ingesting
the capsule the patient may have a light snack. After completion of the study the
patient may return to normal diet.
• The test will last 8 hours. During the test the patient will have to avoid any physical
activity that involves sweating. The patient will have to abstain from bending or
stooping during the test. The patient must be instructed to never remove the belt
during the test.
• At the end of 8 hours, the Sensor Array and Recorder Belt can be removed and
returned as instructed to the physician.
• The M2A™ Capsule is disposable and it will be excreted naturally in the patient’s
bowel movements.
Drug Interactions
•
The patients may take their usual prescribed medication up till two hours before and
resume once again two hours after M2A™ Capsule ingestion, with a sip of water.
\\\DC - 69664/2 - #1258984 v1
•
If the patient is on any medication that may delay gastric emptying (e.g., calcium
channel blocking agents), it is recommended that the taking of this medication be
delayed till after the capsule endoscopy is complete. This, however, should be
discussed with the patient’s treating physician.
Adverse Events
•
•
In patients with strictures of the gastrointestinal tract, the M2A™ Capsule can
potentially cause intestinal obstruction resulting in the need for hospitalization and
surgery. The use of the M2A™ Capsule in patients with strictures of the
gastrointestinal tract is contraindicated.
Based on the experience gained so far, there is no adverse event related to the proper
use of the M2A™ Capsule.
Storage
•
•
•
The M2A™ Capsules should be stored in a dry place away from magnetic sources.
To prevent capsule activation, keep the M2A™ Capsules in the blister box until use.
Even if stored in their original containers and according to recommendations, the
M2A™ Capsules can be kept for a limited period only. Please note the expiration date
of the capsules.
Labeling
•! Read instructions before use
2•
Single Use
Given Imaging Limited
New Industrial Park, P.O.Box 258 Yoqneam,
20692 ISRAEL
www.givenimaging.com
\\\DC - 69664/2 - #1258984 v1

---

Source Exif Data:

File Type                       : PDF
File Type Extension             : pdf
MIME Type                       : application/pdf
PDF Version                     : 1.2
Linearized                      : Yes
Create Date                     : 2001:02:07 22:37:41
Producer                        : Acrobat Distiller 4.0 for Windows
Modify Date                     : 2001:02:07 22:37:43-05:00
Page Count                      : 4

EXIF Metadata provided by EXIF.tools